These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32474824)

  • 1. Comment on "Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision".
    Ranjan KR; Sharma G
    World J Urol; 2021 Jul; 39(7):2815-2816. PubMed ID: 32474824
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.
    Madeira CR; Tonin FS; Fachi MM; Borba HH; Ferreira VL; Leonart LP; Bonetti AF; Moritz RP; Trindade ACLB; Gonçalves AG; Fernandez-Llimos F; Pontarolo R
    World J Urol; 2021 Mar; 39(3):953-962. PubMed ID: 32388784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Seftel A
    J Urol; 2013 Oct; 190(4):1340. PubMed ID: 24029345
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.
    Munk NE; Knudsen JS; Comerma-Steffensen S; Simonsen U
    Sex Med Rev; 2019 Jul; 7(3):430-441. PubMed ID: 30711478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: JinQiu Yuan, RenJie Zhang, ZuYao Yang, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 2013;63:902-12.
    Jiann BP
    Eur Urol; 2014 Mar; 65(3):e40. PubMed ID: 24183420
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis.
    Chen L; Staubli SE; Schneider MP; Kessels AG; Ivic S; Bachmann LM; Kessler TM
    Eur Urol; 2015 Oct; 68(4):674-80. PubMed ID: 25817916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avanafil for treatment of erectile dysfunction: review of its potential.
    Burke RM; Evans JD
    Vasc Health Risk Manag; 2012; 8():517-23. PubMed ID: 22973106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities].
    Puigvert AM; Prieto R; García F
    Rev Int Androl; 2018; 16(1):28-33. PubMed ID: 30063020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Li J; Shi Q; Wei Q; Han P
    Aging Male; 2015 Jun; 18(2):71. PubMed ID: 25162329
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.
    Kaiho Y; Yamashita S; Arai Y
    Int J Urol; 2013 Mar; 20(3):285-9. PubMed ID: 23311962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses.
    Peng Z; Yang L; Dong Q; Wei Q; Liu L; Yang B
    Urol Int; 2017; 99(3):343-352. PubMed ID: 28628914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Du W; Li J; Fan N; Shang P; Wang Z; Ding H
    Aging Male; 2014 Jun; 17(2):107-11. PubMed ID: 24219508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: A review of the literature.
    Afferi L; Pannek J; Louis Burnett A; Razaname C; Tzanoulinou S; Bobela W; da Silva RAF; Sturny M; Stergiopulos N; Cornelius J; Moschini M; Iselin C; Salonia A; Mattei A; Mordasini L
    Andrology; 2020 Nov; 8(6):1660-1673. PubMed ID: 32741129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic management of erectile dysfunction.
    Hawksworth DJ; Burnett AL
    Clin Pharmacol Ther; 2015 Dec; 98(6):602-10. PubMed ID: 26352006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis.
    Yang L; Qian S; Liu L; Pu C; Yuan H; Han P; Wei Q
    Urol Int; 2013; 90(3):339-47. PubMed ID: 23221333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.